Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Theravance Biopharma, Inc. | SVP, DEV & HEAD OF IRE OFFICE | Ordinary Shares | 161K | $1.32M | $8.22 | Aug 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TBPH | Theravance Biopharma, Inc. | Aug 20, 2024 | 1 | -$42.8K | 4 | Aug 22, 2024 | SVP, DEV & HEAD OF IRE OFFICE |
TBPH | Theravance Biopharma, Inc. | May 20, 2024 | 1 | -$47.3K | 4 | May 22, 2024 | SVP, DEV & HEAD OF IRE OFFICE |
TBPH | Theravance Biopharma, Inc. | Apr 2, 2024 | 1 | $0 | 4 | Apr 4, 2024 | SVP, DEV & HEAD OF IRE OFFICE |
TBPH | Theravance Biopharma, Inc. | Feb 20, 2024 | 1 | -$105K | 4 | Feb 22, 2024 | SVP, DEV & HEAD OF IRE OFFICE |
TBPH | Theravance Biopharma, Inc. | Feb 6, 2024 | 0 | $0 | 3 | Feb 16, 2024 | SVP, Dev & Head of IRE Office |